Clinical Trials Logo

Work Related Stress clinical trials

View clinical trials related to Work Related Stress.

Filter by:

NCT ID: NCT05150574 Completed - Health Behavior Clinical Trials

HRV and Coaching Preparation Phase Study

Start date: November 1, 2021
Phase: Phase 1
Study type: Interventional

This pilot study will evaluate possible intervention components to be included in a future stress management and health behaviour change trial and to pilot test their feasibility and acceptability in a small sample.

NCT ID: NCT05100108 Recruiting - Work Related Stress Clinical Trials

A Dog-assisted Therapy to Reduce Burnout Among Professionals Working in a School for Special Education

Start date: October 26, 2021
Phase: N/A
Study type: Interventional

This randomized controlled trial aims to evaluate the effects of an 8-week program consisting of dog-assisted therapy on the work engagement, burnout, pain, and quality of life among professionals working in a School for Special Education. A total of 30 participants will be involved in the program, which will be comprised of eight 50-min sessions conducted once a week. The hypothesis of the researchers in this study is that this program will achieve a reduction in burnout levels in workers, as well as an improvement in engagement and quality of life.

NCT ID: NCT05006976 Active, not recruiting - Depression Clinical Trials

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

NSAC
Start date: September 6, 2021
Phase: N/A
Study type: Interventional

The Norwegian Sickness Absence Clinic (NSAC) Nudge Study is a naturalistic randomized controlled multicentre trial which aim is to measure the efficacy of nudging clinicians' attention towards patients' motivation for work, barriers for return to work and work environment challenges, on functional recovery as primary outcome, and health outcomes as secondary outcome. Patients will be recruited in five different NSACs across northern Norway. In total 1100 patients will be randomized to two equal probability treatment arms: 1) NSAC with the nudge, and 2) NSAC without the nudge. The nudge is tailored to the individual patient's needs using survey, and the clinicians are presented with a summary of this patient survey prior to consultations highlighting health problems and challenges as reported by the patient in the survey.

NCT ID: NCT04809090 Completed - Work Related Stress Clinical Trials

CO-ADAPT: Adaptive Environments and Conversational Agent Based Approaches for Healthy Ageing and Work Ability

Start date: March 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to identify effective methodologies to help people improve their ability to adapt to psychological stress.

NCT ID: NCT04805294 Completed - Work Related Stress Clinical Trials

Pediatrician Wellbeing Program

Start date: September 22, 2020
Phase:
Study type: Observational

The investigators propose to implement a comprehensive Pediatrician Wellbeing Program initiated through and aligning with departmental faculty development and mentorship processes and goals. The Investigators hypothesize that a wellbeing intervention that incorporates an innovative health coaching model to cultivate individual behavior change supportive of one's own and others' wellbeing will lead to improvements in self-reported wellbeing.

NCT ID: NCT04775524 Enrolling by invitation - Stress Clinical Trials

AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This research study is examining the feasibility and effectiveness of an online version of the Storytelling Through Music (STM) program with oncology nurses who have worked during the COVID-19 pandemic.

NCT ID: NCT04752683 Not yet recruiting - Work Related Stress Clinical Trials

Validation of an Employee Remote Workplace Stress Measure Embedded Within a Novel Employee Wellbeing App

Start date: October 2021
Phase:
Study type: Observational [Patient Registry]

This study aims to validate an adapted workplace stress scale (American Institute of Stress) for employees working remotely during the COVID-19 pandemic. Our funding company (BPAi) is a global provider of technology enabled business process services. They offer a range of innovative services and bespoke software solutions, to improve the performance of client networks by increasing revenue, reducing cost, enhancing customer satisfaction. Clients have provided feedback that they require a way to manage, monitor and support their employees' wellbeing while working remotely. The MyBuddy web-based app is in development to meet this need. To best support employees, having an effective measure of workplace stress while working remotely will be a core feature of the app. Thus, this research study was commissioned to validate the measure. A theoretical framework has been developed based on recent models. The measure was adapted based on this theoretical framework (see detailed description). The hypothesis is that our measure will be validated using participants from BPAi's clients (technology/automotive corporations). The investigators hope this study will help to contribute to the evidence base and provide a useful tool in assessing remote workplace stress. Participants will be employees of BPAi's clients taking part in the piloting of the novel employee wellbeing app. Participants will be invited to take part in the research when they first log into the app. Participants will be provided with an information sheet and a consent form. Once they have provided informed consent, they will be prompted to complete the embedded questionnaires (including the once to be validated). After one month, they will be prompted to complete the questionnaires again. Once the data has been collected, their access to the app will end, and the data will be analysed. Once the data has been analysed, the measure will either be validated, or require adaptations and re-validation with a new sample. The research will be written up into a manuscript and submitted to peer-reviewed journals for publication.

NCT ID: NCT04633876 Enrolling by invitation - Metabolic Syndrome Clinical Trials

Effects of 10 Weeks of Lifestyle Coaching on Cardiometabolic Risk Factors, Workability and Subjective Wellbeing

Start date: February 15, 2020
Phase: N/A
Study type: Interventional

The main purpose of this study is to understand the impact of lifestyle coaching on the risk of future cardiometabolic disease, workability and self-assessed wellbeing. The data gathered during the study helps in the future to better identify different focus groups for more tailored interventions. The study consists of two main stages: screening and coaching phase. Screening Aava and the pension will recruit 2000 participants for screening from the employer companies. Screening participants are invited to answer a wellbeing questionnaire (Aava Virta questionnaire, Work Ability Index questionnaire) and give blood samples and physiological measurements, including weight, height, waist circumference, neck circumference and blood pressure. All subjects participating in screening will receive the results from wellbeing questionnaire immediately and they receive the results from blood test within few weeks. Of these 2000 screened persons, a total of 300 high-risk (according to ApoB/ApoA1) individuals and 600 medium-risk individuals will be selected to participate in the coaching phase. These participants are randomly split into treatment and control groups, so that eventually 150 high-risk and 300 medium-risk individuals are placed in both groups. Therefore, a total of 900 subjects carry forward to the coaching phase and in 1100 subjects the study ends. All 900 subjects entering coaching phase receive home a Firstbeat Bodyguard 2 device with instructions for performing Firstbeat wellbeing analysis. After the measurement the device is posted back for analysis according to instructions. The results and feedback from this test is received in the end of the study after the coaching phase. Stage 2: Coaching phase Within the coaching groups, participants in the high-risk category and treatment group undergo an individual coaching program. Participants in the medium-risk category undergo a group coaching program with similar aims. Both coaching programs last 10 weeks during which there are 8 almost weekly coaching sessions at the subjects worksite or near vicinity. Both coaching programs aim in reducing cardiometabolic risk factors and improving subjective well-being. The topics of the lifestyle coaching are 1) nutrition, 2) physical activity, 3) sleep and stress and 4) the long-term maintenance of lifestyle changes. The aims and methods in each coaching topic is based on Finnish recommendations on the topic. The coaching sessions include mostly discussions but in the sessions focusing more on physical activity there are also sessions including activity. In the halfway (5 weeks) of coaching phase, a second blood sampling and Aava wellbeing questionnaire are taken from all subjects (both coaching and control groups). In the end of the coaching phase (10 weeks) blood samples, Aava wellbeing questionnaire, Work Ability Index -questionnaire and physiological measurements are taken the last time. At this stage a second Firstbeat analysis is also performed. BBI-15 questionnaire is administered before and after the coaching phase. An open ended questionnaire regarding lifestyle change motivators and experiences before, during and after the coaching phase is administered to all participants. Also, a small subset (20 persons) of subjects takes in interviews to delve more detailed to the experiences during the study. End of coaching phase and study - start of feedback and analysis After the coaching phase has ended and the subjects (coaching and their control groups) have received all the results (wellbeing questionnaire, blood tests and Firstbeat results) for the study and feedback sessions will be held for all. Willing subjects also receive the results from the gene test in form of PRS scores ie. total genetic risk for three areas of health: heart disease, type 2 diabetes and obesity. THL gene results do not identify single gene variants. After this feedback session the study has ended for the subject. After all data in the study has been gathered starts the analysing and reporting phase for the researchers. At this stage the researchers can retrieve data from Aava patient records to analyse the effect of earlier diagnoses and findings. The information retrieved relate to ICD-10 diagnosis codes C00-C97 (malignant neoplasms), E00-E89 (endocrine, nutritional and metabolic diseases), F00-F99 (mental, behavioral and neurodevelopmental disorders), I00-I99 (diseases of the circulatory system) and M00-M99 (diseases of the musculoskeletal system and connective tissue) as these diagnostic codes can be important background factors for biomarkers of CVD and Type 2 diabetes risk and to some of the secondary endpoints like workability.

NCT ID: NCT04506515 Completed - Covid19 Clinical Trials

Psychological Impact of COVID-19 Pandemic in Healthcare Workers

PSIMCOV
Start date: April 9, 2020
Phase:
Study type: Observational

Background. The current coronavirus disease (COVID-19) has a great impact worldwide. Healthcare workers play an essential role and are one of the most exposed groups.Information about the psychosocial impact on healthcare workers is limited. Methods. 3109 healthcare workers completed a national, internet-based, cross-sectional 45-item survey between 9 and 19 April 2020. The objective is to assess the psychological impact of the COVID-19 pandemic in Spanish healthcare workers. A Psychological Stress and Adaptation at work Score (PSAS) was defined combining four modified versions of validated psychological assessment tests (A) Healthcare Stressful Test, (B) Coping Strategies Inventory,(C) Font-Roja Questionnaire and (D) Trait Meta-Mood Scale.

NCT ID: NCT04398407 Active, not recruiting - Mental Health Clinical Trials

Testing the Effectiveness of Mainstream Management Tools to Increase Organizational Commitment and Job Satisfaction and Decrease Turnover Among Peer Providers

Start date: May 28, 2021
Phase: N/A
Study type: Interventional

The role of peer support specialists (PSS) has burgeoned in the mental health field. Peer support specialists are individuals with a psychiatric condition who are in recovery and who are employed to provide various kinds of tangible and other supports to individuals with psychiatric conditions, generally in public mental health programs. Partially because of the newness of this role, PSS experience confusion about their role and tasks as well as conflict with other mental health providers who are uncertain about how to utilize PSS effectively in services. This project was designed to bring a coaching service to PSS to assist them to address challenges in their job. The investigators will conduct a randomized control trial to evaluate a novel coaching, Coaching and Advancement for Peer Providers (CAPP). Our hypotheses are that individuals participating in the CAPP intervention will experience a reduction in burnout, role confusion, and intention to leave their job or the field. Participants in CAPP will also experience an increase in job satisfaction, role clarity and organizational commitment.